Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scilex Holding Company

6.02
-0.1000-1.63%
Post-market: 5.74-0.2763-4.59%18:58 EDT
Volume:108.77K
Turnover:655.64K
Market Cap:41.54M
PE:-9.88
High:6.32
Open:6.06
Low:5.80
Close:6.12
Loading ...

Scilex Gets FDA Orphan Drug Label for Colchicine for Pericarditis

MT Newswires Live
·
17 Apr

Scilex Gets Orphan Drug Designation for Its Version of Colchicine

Dow Jones
·
17 Apr

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

GlobeNewswire
·
17 Apr

Scilex treatment of pericarditis granted FDA orphan designation

TIPRANKS
·
17 Apr

Scilex announces approval of NDS from Health Canada for ELYXYB

TIPRANKS
·
15 Apr

Scilex Holding Co - Receives Health Canada Approval for Elyxyb for Migraine Treatment

THOMSON REUTERS
·
15 Apr

Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura in Canada

GlobeNewswire
·
15 Apr

Scilex Holding Co trading halted, news pending

TIPRANKS
·
15 Apr

Scilex to Implement 1-for-35 Reverse Stock Split

MT Newswires Live
·
12 Apr

Scilex Holding Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
11 Apr

Scilex downgraded to Hold from Buy at D. Boral Capital

TIPRANKS
·
11 Apr

BRIEF-Scilex Holding Company Announces 1-For-35 Reverse Stock Split

Reuters
·
11 Apr

Scilex Holding Co - Reverse Stock Split Intended to Regain Nasdaq Compliance

THOMSON REUTERS
·
11 Apr

Scilex Holding Co - Stock to Trade on Split-Adjusted Basis From April 15

THOMSON REUTERS
·
11 Apr

Scilex Holding Company Announces 1-for-35 Reverse Stock Split

GlobeNewswire
·
11 Apr

Scilex Holding Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
02 Apr

Scilex Holding Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 Apr

Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

GlobeNewswire
·
27 Mar

Denali Capital Acquisition Pushes Merger Deadline With Extra Funding

MT Newswires Live
·
12 Mar

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025

GlobeNewswire
·
10 Mar